| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.18 | 0.002 |